125 related articles for article (PubMed ID: 16434616)
1. Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells.
Börner C; Höllt V; Kraus J
Mol Pharmacol; 2006 Apr; 69(4):1486-91. PubMed ID: 16434616
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
Börner C; Höllt V; Sebald W; Kraus J
J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4.
Kraus J; Lehmann L; Börner C; Höllt V
Mol Immunol; 2010; 48(1-3):257-63. PubMed ID: 20828825
[TBL] [Abstract][Full Text] [Related]
4. T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors.
Börner C; Kraus J; Bedini A; Schraven B; Höllt V
Mol Pharmacol; 2008 Aug; 74(2):496-504. PubMed ID: 18463202
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6.
Börner C; Kraus J; Schröder H; Ammer H; Höllt V
Mol Pharmacol; 2004 Dec; 66(6):1719-26. PubMed ID: 15448191
[TBL] [Abstract][Full Text] [Related]
6. STAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptors.
Börner C; Wöltje M; Höllt V; Kraus J
J Neurochem; 2004 Dec; 91(6):1493-500. PubMed ID: 15584925
[TBL] [Abstract][Full Text] [Related]
7. Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription.
Börner C; Höllt V; Kraus J
Neuroimmunomodulation; 2007; 14(6):281-6. PubMed ID: 18287809
[TBL] [Abstract][Full Text] [Related]
8. The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene.
Kraus J; Börner C; Giannini E; Höllt V
Mol Pharmacol; 2003 Oct; 64(4):876-84. PubMed ID: 14500744
[TBL] [Abstract][Full Text] [Related]
9. Morphine directs T cells toward T(H2) differentiation.
Roy S; Balasubramanian S; Sumandeep S; Charboneau R; Wang J; Melnyk D; Beilman GJ; Vatassery R; Barke RA
Surgery; 2001 Aug; 130(2):304-9. PubMed ID: 11490364
[TBL] [Abstract][Full Text] [Related]
10. Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine.
Börner C; Martella E; Höllt V; Kraus J
Neuroimmunomodulation; 2012; 19(3):180-6. PubMed ID: 22262103
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor REST negatively influences the protein kinase C-dependent up-regulation of human mu-opioid receptor gene transcription.
Bedini A; Baiula M; Carbonari G; Spampinato S
Neurochem Int; 2010 Jan; 56(2):308-17. PubMed ID: 19913583
[TBL] [Abstract][Full Text] [Related]
12. The potential promoter regions on the 5' flank sequence of the mu opioid receptor gene in lymphocytes.
Wei E; Li P; Liu X; Qian C; Li H; Xia W; Li G
J Cell Biochem; 2005 Aug; 95(6):1204-13. PubMed ID: 15988758
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma down-regulates transcription of the mu-opioid receptor gene in neuronal and immune cells.
Kraus J; Börner C; Lendeckel U; Höllt V
J Neuroimmunol; 2006 Dec; 181(1-2):13-8. PubMed ID: 16914208
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ERK1/2 phosphorylation by acute and chronic morphine - implications for the role of cAMP-responsive element binding factor (CREB)-dependent and Ets-like protein-1 (Elk-1)-dependent transcription; small interfering RNA-based strategy.
Ligeza A; Wawrzczak-Bargiela A; Kaminska D; Korostynski M; Przewlocki R
FEBS J; 2008 Aug; 275(15):3836-49. PubMed ID: 18616461
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of opioid-mediated inhibition of human T cell receptor signaling.
Börner C; Warnick B; Smida M; Hartig R; Lindquist JA; Schraven B; Höllt V; Kraus J
J Immunol; 2009 Jul; 183(2):882-9. PubMed ID: 19561113
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of mu-opioid receptor expression in immune and neuronal cells.
Börner C; Stumm R; Höllt V; Kraus J
J Neuroimmunol; 2007 Aug; 188(1-2):56-63. PubMed ID: 17561272
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation.
McCoy KL; Matveyeva M; Carlisle SJ; Cabral GA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1620-5. PubMed ID: 10336560
[TBL] [Abstract][Full Text] [Related]
19. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
Bayerer B; Stamer U; Hoeft A; Stüber F
Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation.
Daaka Y; Friedman H; Klein TW
J Pharmacol Exp Ther; 1996 Feb; 276(2):776-83. PubMed ID: 8632350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
